Microbiology & Infectious Diseases

Global vaccine coverage has improved since 1980 but stalled and declined during COVID-19, with millions of zero-dose children concentrated in a few countries, risking setbacks to immunisation goals.

Early trial data show that olorofim may offer a valuable new option for patients with resistant invasive fungal infections.

High ICU admission rates and atypical features marked France’s recent M. pneumoniae epidemic, especially in those without early macrolide therapy.

A German multicentre study shows MVA-BN vaccination is safe and moderately effective in preventing mpox, especially in HIV-negative individuals.

Delayed sputum conversion and poor outcomes are common in patients with bedaquiline-resistant TB, according to a new South African cohort study.

Europe faces a sharp rise in hepatitis A cases, with over 2,000 infections in 2025. Vulnerable groups are most affected as ECDC urges vaccination and sanitation efforts.

More than half of residents in European care homes experience at least one healthcare-associated infection each year, according to a major ECDC-led study.

Genetic data show that salicylic acid may alter gut microbiota and blood metabolites, raising questions about its long-term effects.